SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 65964.
  • 2
    Eliakim M, Levy M, Ehrenfeld M. Recurrent polyserositis (familial Mediterranean fever, periodic disease). New York: Elsevier North-Holland; 1981. p. 514.
  • 3
    Goldfinger SE. Colchicine for familial Mediterranean fever [letter]. N Engl J Med 1972; 287: 1302.
  • 4
    Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 47383.
  • 5
    Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al, for the Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84: 111.
  • 6
    Cobankara V, Fidan G, Turk T, Zencir M, Colakoglu M, Ozen S. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 2004; 22 Suppl 34: S2730.
  • 7
    Daniels M, Shohat T, Brenner-Ullman A, Shohat M. Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 2005; 55: 3114.
  • 8
    Sarkisian T, Ajrapetian H, Beglarian A, Shahsuvarian G, Egiazarian A. Familial Mediterranean fever in Armenian population. Georgian Med News 2008; 156: 10511.
  • 9
    Medlej-Hashim M, Serre JL, Corbani S, Saab O, Jalkh N, Delague V, et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet 2005; 48: 41220.
  • 10
    Mattit H, Joma M, Al-Cheikh S, El-Khateeb M, Medlej-Hashim M, Salem N, et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 2006; 49: 4816.
  • 11
    Belmahi L, Sefiani A, Fouveau C, Feingold J, Delpech M, Grateau G, et al. Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. C R Biol 2006; 329: 714.
  • 12
    Fragouli E, Eliopoulos E, Petraki E, Sidiropoulos P, Aksentijevich I, Galanakis E, et al. Familial Mediterranean fever in Crete: a genetic and structural biological approach in a population of ‘intermediate risk.’ Clin Genet 2008; 73: 1529.
  • 13
    Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 2007; 71: 45867.
  • 14
    La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003; 11: 506.
  • 15
    Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, et al. MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol 2008; 26: 37.
  • 16
    Sugiura T, Kawaguchi Y, Fujikawa S, Hirano Y, Igarashi T, Kawamoto M, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol 2008; 18: 18579.
  • 17
    French Familial Mediterranean Fever Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 2531.
  • 18
    The International Familial Mediterranean Fever Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797807.
  • 19
    Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998; 7: 131725.
  • 20
    Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The Infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008; 29: 8038.
  • 21
    Aldea A, Calafell F, Arostegui JI, Lao O, Rius J, Plaza S, et al. The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination “hot-spot” at the MEFV locus. Hum Mutat 2004; 23: 399.
  • 22
    Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 94962.
  • 23
    Buades J, Ben-Chetrit E, Levy M. Familial Mediterranean fever in the “Chuetas” of Mallorca: origin in inquisition? Isr J Med Sci 1995; 31: 4979.
  • 24
    Domingo C, Touitou I, Bayou A, Ozen S, Notarnicola C, Dewalle M, et al. Familial Mediterranean fever in the ‘Chuetas’ of Mallorca: a question of Jewish origin or genetic heterogeneity. Eur J Hum Genet 2000; 8: 2426.
  • 25
    Kovacs G, Tarjan E, Magyar P, Nagy E, Muzes G, Ben-Chetrit E. Identification of familial Mediterranean fever (FMF) in a Gypsy woman: a case report. Clin Exp Rheumatol 2007; 25(4 Suppl 45 ): S119.
  • 26
    Livneh A, Aksentijevich I, Langevitz P, Torosyan Y, G-Shoham N, Shinar Y, et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet 2001; 9: 1916.
  • 27
    Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, et al. MEFV mutations in Behçet's disease. Hum Mutat 2000; 16: 2712.
  • 28
    Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998; 6: 957.
  • 29
    Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford) 2000; 39: 6772.
  • 30
    Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T. MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 2005; 25: 2559.
  • 31
    Dusunsel R, Dursun I, Gunduz Z, Poyrazoglu MH, Gurgoze MK, Dundar M. Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr Int 2008; 50: 20812.
  • 32
    Hershko AY, Ben-Chetrit E. The MEFV E148Q allele: a deleterious mutation or harmless variation? Clin Exp Rheumatol 2006; 24(5 Suppl 42 ): S512.
  • 33
    Pras M, Bronshpigel N, Zemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 1982; 150: 226.
  • 34
    Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians: analysis of 100 cases. Medicine (Baltimore) 1974; 53: 45362.
  • 35
    Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009; 68: 2468.
  • 36
    Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al, for the International Study Group for Phenotype–Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007; 56: 170612.
  • 37
    Sidi G, Shinar Y, Livneh A, Langevitz P, Pras M, Pras E. Protracted febrile myalgia of familial Mediterranean fever: mutation analysis and clinical correlations. Scand J Rheumatol 2000; 29: 1746.
  • 38
    Ben-Chetrit E, Ben-Chetrit A. Familial Mediterranean fever and menstruation. BJOG 2001; 108: 4037.
  • 39
    Pearce JM. Mollaret's meningitis. Eur Neurol 2008; 60: 3167.
  • 40
    Yalcinkaya F, Cakar N, Acar B, Tutar E, Guriz H, Elhan AH, et al. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study. Rheumatol Int 2007; 27: 51722.
  • 41
    Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, et al. A single testing of serum amyloid A levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum 2007; 37: 1828.
  • 42
    Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007; 119: 47483.
  • 43
    Ben-Chetrit E, Scherrmann JM, Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum 1996; 39: 12137.
  • 44
    Savgan-Gurol E, Kasapcopur O, Hatemi S, Ercan O, Caliskan S, Sever L, et al. Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment. Clin Exp Rheumatol 2001; 19 Suppl 24: S725.
  • 45
    Ben-Chetrit E, Ozdogan H. Non-response to colchicine: definition, causes and suggested solutions. Clin Exp Rheumatol 2008; 26 Suppl 50: S4951.
  • 46
    Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol 2006; 24 Suppl 42: S99103.
  • 47
    Roldan R, Ruiz AM, Miranda MD, Collantes E. Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine. Joint Bone Spine 2008; 75: 5045.
  • 48
    Calligaris L, Marchetti F, Tommasini A, Ventura A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr 2008; 167: 6956.
  • 49
    Ortiz-Santamaria V, Valls-Roc M, Sanmarti M, Olive A. Anti-TNF treatment in secondary amyloidosis [letter]. Rheumatology (Oxford) 2003; 42: 14256.
  • 50
    Fernandez-Nebro A, Urena I, Irigoyen MV, Garcia-Vicuna R. Anti-TNF-α for treatment of amyloidosis associated with Crohn's disease [letter]. Gut 2006; 55: 16667.
  • 51
    Nakamura A, Yazaki M, Tokuda T, Hattori T, Ikeda S. A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. Intern Med 2005; 44: 1778.
  • 52
    Oganesian LA, Farmanian AK, Avetisian VA. On the problem of the so-called periodic disease. Klin Med (Mosk) 1969; 43: 1923. In Russian.
  • 53
    Armenian HK, Khachadurian AK. Familial paroxysmal polyserositis: clinical and laboratory findings of 120 cases. J Med Liban 1973; 26: 60514.
  • 54
    Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 22753.
  • 55
    Eliakim M, Rachmilewitz M, Rosenmann E, Niv A. Renal manifestations in recurrent polyserositis (familial Mediterranean fever). Isr J Med Sci 1970; 6: 22845.
  • 56
    Barakat MH, Karnik AM, Majeed HW, El Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs: a study of 175 patients and review of the literature. Q J Med 1986; 60: 83747.
  • 57
    Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. In press.